Wedbush Securities’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-19,100
| Closed | -$47K | – | 1014 |
|
2020
Q3 | $47K | Sell |
19,100
-12,500
| -40% | -$30.8K | ﹤0.01% | 888 |
|
2020
Q2 | $112K | Sell |
31,600
-2,300
| -7% | -$8.15K | 0.01% | 847 |
|
2020
Q1 | $79K | Sell |
33,900
-8,577
| -20% | -$20K | 0.01% | 794 |
|
2019
Q4 | $93K | Sell |
42,477
-20,223
| -32% | -$44.3K | 0.01% | 931 |
|
2019
Q3 | $115K | Sell |
62,700
-58,235
| -48% | -$107K | 0.01% | 885 |
|
2019
Q2 | $175K | Buy |
120,935
+7,200
| +6% | +$10.4K | 0.02% | 855 |
|
2019
Q1 | $224K | Sell |
113,735
-31,400
| -22% | -$61.8K | 0.02% | 724 |
|
2018
Q4 | $190K | Sell |
145,135
-10,850
| -7% | -$14.2K | 0.02% | 690 |
|
2018
Q3 | $384K | Sell |
155,985
-63,843
| -29% | -$157K | 0.04% | 496 |
|
2018
Q2 | $739K | Sell |
219,828
-28,083
| -11% | -$94.4K | 0.09% | 257 |
|
2018
Q1 | $1.05M | Sell |
247,911
-29,266
| -11% | -$124K | 0.14% | 178 |
|
2017
Q4 | $915K | Buy |
277,177
+17,485
| +7% | +$57.7K | 0.11% | 221 |
|
2017
Q3 | $992K | Buy |
259,692
+25,000
| +11% | +$95.5K | 0.13% | 175 |
|
2017
Q2 | $1.03M | Buy |
234,692
+55,000
| +31% | +$242K | 0.13% | 183 |
|
2017
Q1 | $652K | Buy |
179,692
+5,999
| +3% | +$21.8K | 0.09% | 275 |
|
2016
Q4 | $464K | Sell |
173,693
-7,252
| -4% | -$19.4K | 0.07% | 355 |
|
2016
Q3 | $590K | Sell |
180,945
-30,998
| -15% | -$101K | 0.09% | 270 |
|
2016
Q2 | $710K | Sell |
211,943
-650
| -0.3% | -$2.18K | 0.12% | 195 |
|
2016
Q1 | $519K | Sell |
212,593
-130
| -0.1% | -$317 | 0.09% | 249 |
|
2015
Q4 | $698K | Buy |
212,723
+12,575
| +6% | +$41.3K | 0.13% | 181 |
|
2015
Q3 | $689K | Buy |
200,148
+3,000
| +2% | +$10.3K | 0.14% | 172 |
|
2015
Q2 | $262K | Sell |
197,148
-10,378
| -5% | -$13.8K | 0.05% | 473 |
|
2015
Q1 | $174K | Sell |
207,526
-1,000
| -0.5% | -$838 | 0.03% | 602 |
|
2014
Q4 | $83K | Buy |
208,526
+7,825
| +4% | +$3.12K | 0.01% | 659 |
|
2014
Q3 | $873K | Buy |
200,701
+6,855
| +4% | +$29.8K | 0.14% | 146 |
|
2014
Q2 | $960K | Buy |
+193,846
| New | +$960K | 0.15% | 137 |
|